A2P2 has been applied across regulated medical device manufacturing and adjacent industrial polymer systems. The framework has been validated against external literature, many industry case studies on medical device materials, and eight years of continuous field service data on a polyamide composite separation membrane. Cross-material reproducibility has been confirmed across chemically distinct polymer families and is documented in the FDA MDDT submission.
Each entry represents a documented deployment of the A2P2 methodology against a defined material system and degradation mechanism. Full study designs, sample sizes, methods, endpoints, and statistical criteria are documented in the qualification plan submitted under MDDT. Anonymised deployment summaries are available to qualified licence enquirers under non-disclosure agreement.
Case Study: Extending Tubing Lifespan Beyond Manufacturer's 1-Year Recommendation
Challenge
The manufacturer recommended replacing the biopharmaceutical tubing every 12 months, likely to drive frequent purchases. This short lifespan led to high replacement costs and production downtime.
Solution
We optimised cleaning methods, added mandatory drying, conducted monthly inspections to extend lifespan.
Results
Tubing lifespan reached 28.5 months (137.5% improvement), maintaining safe performance under operational conditions.
Benefits
Cost Efficiency: Reduced replacement frequency, cutting expenses.
Enhanced Productivity: Less downtime increased output.
Improved Safety: Regular inspections minimized failure risks.
Sustainability: Longer-lasting tubing reduced waste.
